Eosinophilic angiocentric fibrosis, IgG-related head and neck disease

Authors

  • Hugo N. Cabrera Faculty of Medicine of the University of Buenos Aires, Office of Prof. Dr. Hugo Cabrera, Autonomous City of Buenos Aires, Argentina
  • Silvia Pérez Office of Prof. Dr. Hugo Cabrera, Autonomous City of Buenos Aires, Argentina
  • María Fernanda Carriquiri Office of Prof. Dr. Hugo Cabrera, Autonomous City of Buenos Aires, Argentina
  • José Casasꝉ Office of Prof. Dr. Hugo Cabrera, Autonomous City of Buenos Aires, Argentina

Keywords:

angiocentric fibrosis, IgG related disease

Abstract

Eosinophilic angiocentric fibrosis is a fibrosing inflammatory condition of the upper airways, sinuses, orbit, salivary and lacrimal glands, with cutaneous involvement usually over the nose; there is nasal deformation and obstruction, with erythematous plaques on its surface. It is of rare observation; less than 60 cases have been published, and it is included within the group of IgG4-related diseases. We present the case of an adult woman with facial skin involvement and respiratory obstructive symptoms, with normal serum IgG4, and a satisfactory response to methotrexate.

Author Biographies

Hugo N. Cabrera, Faculty of Medicine of the University of Buenos Aires, Office of Prof. Dr. Hugo Cabrera, Autonomous City of Buenos Aires, Argentina

Emeritus Professor of Dermatology

Silvia Pérez, Office of Prof. Dr. Hugo Cabrera, Autonomous City of Buenos Aires, Argentina

Dermatologist

María Fernanda Carriquiri, Office of Prof. Dr. Hugo Cabrera, Autonomous City of Buenos Aires, Argentina

Dermatologist

José Casasꝉ, Office of Prof. Dr. Hugo Cabrera, Autonomous City of Buenos Aires, Argentina

Dermatopathologist

References

I. Mulholland GB, Jeffery CC, Satija P, Colé DWJ. Immunoglobulin G4-related diseases in the head and neck; a systematic review. J Otolaryngol Head Neck Surg. 2015;44:24-26.

II. Gorostis S, Bacha M, Gravier S, Raguin T. Right ethmoid eosinophilic angiocentric fibrosis with orbital extension. Eur Ann Otorhinolaryngol Head Neck Dis. 2017;134(5):351-354.

III. Holmes DK, Panje WR. Intranasal granuloma faciale. Am J Otolaryngol. 1983;4:184-186.

IV. Roberts PF, Cann BG. Eosinophilic angiocentric fibrosis of the upper respiratory tract; a mucosal variant of granuloma faciale? A report of three cases. Histopathology. 1985;9:1217-1225.

V. Thompson LD, Heffner DK. Sinonasal tract eosinophilic angiocentric fibrosis: a report of three cases. Am J Clin Pathol. 2001;115:243-248.

VI. Ahn J, Flanagan M. Eosinophilic angiocentric fibrosis. A review and update of its association with immunoglobulin G4-related disease. Arch Pathol Lab Med. 2018;142:1560-1563.

VII. Deshpande V, Khosroshahi A, Nielsen GP, Hamilos DL, et ál. Eosinophilic angiocentric fibrosis is a form of IgG4-related systemic disease. Am J Surg Pathol. 2011;35:701-706.

VIII. Wallace ZS, Naden RP, Chari S, Choi H, et ál. The 2019 American College Rheumatology/European league against rheumatism classification criteria for IgG4-related disease. Arthritis Rheumatol. 2020;72:7-19.

IX. Xiang JK, Fang RY, Zhang S, Yan Y, et ál. Image gallery: concomitant eosinophilic angiocentric fibrosis and granuloma faciale. Br J Dermatol. 2018;178: e395.

X. Popkirov S, Kowalski T, Schlegel U, Skodda S. Immunoglobulin-G4-related hypertrophic pachymeningitis with antineutrophil cytoplasmatic antibodies effectively treated with rituximab. J Clin Neurosci. 2015;22:1038-1040.

Published

2022-09-01

Issue

Section

Original Articles